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Hcm1 integrates signals from Cdk1 and 
calcineurin to control cell proliferation
ABSTRACT Cyclin-dependent kinase (Cdk1) orchestrates progression through the cell cycle 
by coordinating the activities of cell-cycle regulators. Although phosphatases that oppose 
Cdk1 are likely to be necessary to establish dynamic phosphorylation, specific phosphatases 
that target most Cdk1 substrates have not been identified. In budding yeast, the transcrip-
tion factor Hcm1 activates expression of genes that regulate chromosome segregation and is 
critical for maintaining genome stability. Previously we found that Hcm1 activity and degra-
dation are stimulated by Cdk1 phosphorylation of distinct clusters of sites. Here we show 
that, upon exposure to environmental stress, the phosphatase calcineurin inhibits Hcm1 by 
specifically removing activating phosphorylations and that this regulation is important for 
cells to delay proliferation when they encounter stress. Our work identifies a mechanism by 
which proliferative signals from Cdk1 are removed in response to stress and suggests that 
Hcm1 functions as a rheostat that integrates stimulatory and inhibitory signals to control cell 
proliferation.
INTRODUCTION
Cyclin-dependent kinases (Cdks) orchestrate progression through 
the cell division cycle by phosphorylating hundreds of regulatory 
proteins in a defined order (Ubersax et al., 2003; Holt et al., 2009). 
Disruption of this ordered phosphorylation can result in errors in 
DNA replication and chromosome segregation that can be lethal or 
result in genomic instability that can lead to cancer (Hanahan and 
Weinberg, 2011). The activities of Cdks are opposed by phospha-
tases, which are equally important for establishing the cyclical phos-
phorylation patterns that drive the cell cycle. However, whereas a 
great deal is known about how Cdks recognize and target sub-
strates, much less is known about the phosphatases that antagonize 
Cdk function (Mochida and Hunt, 2012). The best-understood phos-
phatases that function in cell cycle control are those that counteract 
Cdk1 to regulate mitosis. These include Cdc14, PP1, and PP2A 
(Visintin et al., 1998; Domingo-Sananes et al., 2011; Wurzenberger 
and Gerlich, 2011; Grallert et al., 2015). In addition, a few phospha-
tases, including PP2A (Mochida and Hunt, 2007; Alvarez-Fernández 
et al., 2011), PP4 (Toyo-oka et al., 2008), and Caenorhabditis ele-
gans CDC-14 (Saito et al., 2004), have been found to remove Cdk-
catalyzed phosphorylations in interphase. However, for the majority 
of Cdk substrates, their cognate phosphatases remain to be identi-
fied, and the extent to which phosphatases play direct roles in con-
trolling progression through interphase is not known.
The calcium-activated phosphatase PP2B/calcineurin (CN) has 
also been implicated in cell cycle control. CN is required for pro-
gression through meiosis in Xenopus and Drosophila (Cao et al., 
2006; Mochida and Hunt, 2007; Nishiyama et al., 2007; Takeo 
et al., 2010). In Xenopus oocytes, CN directly removes Cdk1-cata-
lyzed phosphorylations from substrates to trigger cell cycle reeen-
try (Cao et al., 2006; Mochida and Hunt, 2007). The role of CN in 
controlling the mitotic cell cycle is less clear. Positive genetic inter-
actions between Cdk1 (cdc28) and CN (cnb1) mutants in budding 
yeast suggest that CN may antagonize Cdk1 phosphorylation, and 
CN targets include known Cdk1 substrates (Fiedler et al., 2009; 
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(Sarin et al., 2004; Tong et al., 2004; Daniel 
et al., 2006). Thus proper regulation of 
Hcm1 activity is critical for cells to maintain 
a stable genome.
We recently found that Cdk1 phosphor-
ylation of Hcm1 is required for both its acti-
vation, by promoting chromatin binding, 
and its degradation via the ubiquitin-prote-
asome system (Landry et al., 2014). Of in-
terest, these opposing outcomes are medi-
ated by phosphorylation of distinct clusters 
of Cdk1 phosphosites. It is not known 
whether or how these antagonistic phos-
phosites are differentially regulated in or-
der to establish a window of Hcm1 activity 
during the cell cycle. One possibility is that 
the two clusters of sites are phosphorylated 
by Cdk1 with different efficiencies and/or 
by distinct cyclin/Cdk1 complexes. A sec-
ond possibility is that the activating and 
destabilizing sites are phosphorylated si-
multaneously but with one group of sites 
being differentially regulated by a phos-
phatase. Here we provide evidence that 
activating phosphorylations on Hcm1 are 
specifically removed by the phosphatase 
CN. We find that by removing activating 
phosphorylations but not targeting the de-
stabilizing phosphosites, CN inactivates 
Hcm1 without disrupting ubiquitin-medi-
ated degradation. This decrease in Hcm1 
activity contributes to decreased prolifera-
tion in response to stress, since blocking 
Hcm1 dephosphorylation allows cells to 
proliferate better in response to CN-acti-
vating stresses. In addition, cells express-
ing a CN-resistant mutant of Hcm1 are fit-
ter than wild type cells in the absence of 
stress, demonstrating that CN directly antagonizes Cdk1 activity to 
control proliferation.
RESULTS AND DISCUSSION
Phosphorylation of Hcm1 regulates proliferation
Hcm1 activates expression of genes that regulate chromosome seg-
regation and mitosis (Pramila et al., 2006). As a result, deletion or 
inactivation of HCM1 affects progression through the cell cycle. This 
cell cycle defect is easily observed when mutant cells are cocultured 
with wild-type cells in a competitive fitness assay, which is a sensitive 
growth assay that reveals differences in proliferation rate. Previously 
we found that blocking all phosphorylation of Hcm1 by Cdk1 led to 
a reduction in cellular fitness (hcm1-15A; Figure 1B; Landry et al., 
2014), thus demonstrating that regulation of Hcm1 by Cdk1 is criti-
cal for robust proliferation.
Here we wanted to address whether phosphoregulation limits 
Hcm1 activity during the cell cycle. To answer this question, we ex-
amined the fitness of cells expressing Hcm1 phosphosite mutants 
that have increased activity. Strains expressing a mutant that is 
highly expressed because it cannot be phosphorylated on destabi-
lizing sites (hcm1-3N) and a mutant that is constitutively active be-
cause it has mutations that mimic phosphorylation at activating 
Cdk1 sites (hcm1-16E; Figure 1A; Landry et al., 2014) were tested in 
coculture assays with wild-type cells. Remarkably, increasing Hcm1 
Goldman et al., 2014). Moreover, CN activation delays the cell cy-
cle in yeast strains lacking Zds1 and Zds2 (Miyakawa and Mizunuma, 
2007), which are regulatory subunits of the phosphatase PP2A 
(Rossio and Yoshida, 2011), suggesting that CN and PP2A may act 
redundantly to arrest the cell cycle in some contexts. In addition, 
our recent work identified a number of CN targets involved in po-
larized growth, which is coordinated with the cell cycle (Goldman 
et al., 2014). Thus, although a role for yeast CN in mitotic cell cycle 
regulation seems likely, this function has yet to be elucidated.
Among the key targets of Cdks in all eukaryotes are cell cycle–
regulatory transcription factors, which coordinate gene expression 
with the cell cycle (Bertoli et al., 2013; Sadasivam and DeCaprio, 
2013). In budding yeast, Cdk1 phosphorylation regulates the activ-
ity of the forkhead family transcription factor Hcm1, which is a ho-
mologue of the human oncogene FoxM1 (Myatt and Lam, 2007). 
Like FoxM1, Hcm1 activates expression of genes that are required 
for accurate chromosome segregation, including molecular motors, 
components of the spindle pole body, and the kinetochores 
(Laoukili et al., 2005; Pramila et al., 2006; Grant et al., 2013). Consis-
tent with the functions of these target genes, mutations that inacti-
vate Hcm1 sensitize cells to microtubule poisons that destabilize 
the mitotic spindle (Horak et al., 2002; Daniel et al., 2006), cause an 
increased rate of chromosome loss (Pramila et al., 2006), and are 
lethal when combined with mutations in spindle checkpoint genes 
FIGURE 1: Hcm1 phosphorylation affects cellular fitness. (A) Positions of Cdk1 phosphosites 
that activate (green) and destabilize Hcm1 (red). Mutations that block degradation lead to an 
increase in protein level (15A, 3N, 3N/16E); phosphomimetic mutations (16E, 3N/16E) lead to 
constitutive activity (CA). (B) Strains expressing PGK1-URA3 (blue lines) and PGK1-GFP-URA3 
(red lines) were cocultured and the percentage of each strain in the population determined at 
the indicated time points. Average values ±1 SD of five to eight replicates.
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CN was found to target several Cdk1 
substrates in a recent proteomic screen 
(Goldman et al., 2014), it is not known 
whether it directly regulates proliferation. To 
determine whether CN regulates prolifera-
tion via dephosphorylation of Hcm1, we ex-
amined Hcm1 phosphorylation in vivo after 
CN activation. We first established a West-
ern blotting assay using Phos-tag reagent, 
which enables the resolution of individual 
phosphosites upon its addition to a poly-
acrylamide gel (Kinoshita et al., 2006). Un-
der these gel conditions, the phosphoryla-
tion status of a panel of Hcm1 mutants with 
different numbers of Cdk1 phosphosites is 
clearly distinguishable (Figure 2, A and C). In 
addition, we found that within 10 min of di-
rect CN activation by the addition of CaCl2 
to the growth medium, Hcm1 was dramati-
cally dephosphorylated (Figure 2D). This de-
phosphorylation was blocked by deletion of 
the CN docking site in Hcm1 (ΔP; Figure 2D), 
by deletion of the regulatory subunit of CN, 
Cnb1 (Figure 2D), or upon addition of the 
CN inhibitor FK506 (Figure 2E). These data 
demonstrate that Hcm1 is dephosphory-
lated by CN in vivo.
Of note, Hcm1 retained some phosphor-
ylation after CN activation (Figure 2, D and 
E), suggesting that CN might target only a 
subset of Hcm1 phosphosites. To test this, 
we examined CN-dependent dephosphory-
lation of previously characterized mutants in 
which all Cdk1 sites were mutated except for 
the eight activating Cdk1 sites (Hcm1-7N, 
with 7 N-terminal S/T-P sites mutated to A-P; 
Figure 2A) or the three destabilizing Cdk1 
sites (Hcm1-12C, with 12 C-terminal S/T-P 
sites mutated to A-P; Figure 2A; Landry et al., 2014). Of interest, 
Hcm1-7N was almost completely dephosphorylated after CN activa-
tion, whereas Hcm1-12C phosphorylation was largely unchanged 
(Figure 3A). This specificity was also observed in vitro. Recombinant 
Hcm1 proteins were phosphorylated with Clb2/Cdk1 and then incu-
bated with or without purified CN. Consistent with the in vivo results, 
CN dephosphorylated wild-type Hcm1 and Hcm1-7N but had no ef-
fect on Hcm1-12C (Figure 3B and Supplemental Figure S1B). In addi-
tion, deletion of the PSIEIQ motif impaired Hcm1 dephosphorylation 
in vitro (Figure 3B and Supplemental Figure S1B), although it was not 
completely blocked. This partial dephosphorylation of the ΔPSIEIQ 
mutant suggests that this motif is less important to mediate the inter-
action between CN and Hcm1 in vitro than in vivo, where there are 
hundreds of other CN targets present that reduce the concentration 
of available CN. These results show that Hcm1 can be directly de-
phosphorylated by CN and demonstrate that CN has specificity for 
C-terminal Cdk1 sites that are required for Hcm1 activity.
Calcineurin inactivates Hcm1
To determine the consequences of Hcm1 dephosphorylation, we 
first examined whether CN regulates Hcm1 expression. If CN does 
not target N-terminal Cdk1 sites that promote phosphorylation-
mediated degradation of Hcm1, as our data suggest (Figure 3, A 
and B), then CN activation should not stabilize Hcm1. Consistent 
activity by either mechanism caused cells to outcompete wild-type 
cells to a similar extent, as did combining both sets of mutations 
(Figure 1B). These results indicate that Hcm1 activity is normally lim-
iting for maximal proliferation. Moreover, because the phosphomi-
metic mutant showed a dramatic fitness advantage, this suggested 
that the activating sites on Hcm1 are not always fully phosphory-
lated in wild-type cells and that a phosphatase may critically regu-
late Hcm1 activity in vivo.
Hcm1 is a target of the phosphatase calcineurin
In a previous yeast two-hybrid screen, we identified Hcm1 as a can-
didate substrate of the conserved Ca2+-activated phosphatase CN 
(unpublished data). Hcm1 interacted with the CN-regulatory subunit 
Cna1 in this assay, and the interaction was eliminated upon deletion 
of a six–amino acid sequence on Hcm1 (PSIEIQ; Figure 2, A and B) 
that matches the consensus for the previously identified CN dock-
ing-site sequence (Roy et al., 2007). In addition, we found that Hcm1 
associated with Cna2 in vivo, and this interaction was inhibited by 
deletion of the docking site (Supplemental Figure S1A). These data 
suggest that CN might antagonize Hcm1 phosphorylation by Cdk1 
to regulate its activity and affect proliferation.
The best-understood role of CN in yeast is to promote cell sur-
vival in response to environmental stresses that signal through an 
increase in intracellular Ca2+ (Cyert and Philpott, 2013). Although 
FIGURE 2: Hcm1 is dephosphorylated by calcineurin in vivo. (A) Diagram of Hcm1 mutants 
assayed in B–D, along with the number of Cdk1 (S/T-P) sites retained in each protein. (B) Yeast 
two-hybrid assay showing interaction between Hcm1 and Cna1. Deletion of the docking site 
(hcm1ΔPSIEIQ) disrupts the interaction. (C) Western blots comparing separation of Hcm1 
proteins that contain different numbers of Cdk1 sites on a Phos-tag gel (top) and standard 
SDS–PAGE (bottom). (D) Phos-tag Western blot of strains expressing Hcm1-15A (15A, no Cdk1 
sites), wild-type Hcm1 (WT), Hcm1ΔPSIEIQ (ΔP), or wild-type Hcm1 in a cnb1Δ strain assayed 
after the addition of CaCl2 for 10 min and compared with untreated control cells. (E) Hcm1 
phosphorylation assayed as in D, except that cells were treated with FK506 or ET buffer for 1 h 
and then CaCl2 was added for 15 min.
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that more than half of predicted Hcm1 
target genes were down-regulated after 
cells were treated with CaCl2 and that this 
down-regulation was largely reversed 
when CN was inhibited by FK506 
(Figure 4, A and B). We next confirmed 
these findings by examining expression of 
a subset of these genes that we previ-
ously demonstrated are direct Hcm1 tar-
gets (Landry et al., 2014). Each of these 
targets was down-regulated after CaCl2 
treatment in wild-type cells (blue bars, 
Figure 4C). Of note, the extent of down-
regulation observed was similar to the de-
crease in peak expression of these genes 
that occurs during a normal S phase when 
Hcm1 has been inactivated or deleted 
(Landry et al., 2014), consistent with the 
prediction that dephosphorylation inacti-
vates Hcm1. Moreover, target gene 
expression was largely unchanged in 
cells expressing the Hcm1 docking-site 
mutant (hcm1ΔPSIEIQ) or Hcm1-16E, 
which contains phosphomimetic muta-
tions in activating Cdk1 sites and restores 
Hcm1 binding to each of these promoters 
(red and green bars, Figure 4C; Landry 
et al., 2014). Of importance, wild-
type and mutant cells displayed similar 
cell cycle distributions after CaCl2 treat-
ment (Supplemental Figure S2B), ruling 
out this potential indirect effect on ex-
pression of Hcm1 target genes. Moreover, 
hcm1ΔPSIEIQ cells did not exhibit sensi-
tivity to the microtubule poison benomyl 
(Supplemental Figure S2C), confirming 
that Hcm1ΔPSIEIQ is a functional protein. 
These findings demonstrate that CN im-
pairs Hcm1 activation and are consistent 
with our other data suggesting that acti-
vating sites on Hcm1 are selectively 
dephosphorylated by CN.
Dephosphorylation of Hcm1 by calcineurin impairs 
proliferation
Although no role for CN in control of an unperturbed cell cycle has 
been described, the fact that the hcm1-16E phosphomimetic mu-
tant outcompetes a wild-type strain in coculture assays suggests 
that Hcm1 is not fully phosphorylated when cells are grown in rich 
medium without any additional stresses (Figure 1B) and that a phos-
phatase may actively remove phosphorylations at these sites. To 
determine whether CN plays a role in this regulation, we tested 
whether the Hcm1ΔPSIEIQ mutant, which severely impairs dephos-
phorylation of these same sites (Figure 3 and Supplemental Figure 
S1B), displays a similar increase in fitness. Indeed, hcm1ΔPSIEIQ 
cells consistently exhibited a modest proliferative advantage in this 
assay (Figure 5A), suggesting that there may be a low level of CN 
activity in normal growth conditions and that CN contributes to the 
phosphorylation status of Hcm1.
CN is strongly activated in response to several types of environ-
mental stress, including alkaline pH (Viladevall et al., 2004), toxic cat-
ions (Nakamura et al., 1993; Matsumoto et al., 2002), and cell wall 
with this prediction, CaCl2 treatment did not lengthen Hcm1 half-life 
(Figure 3, C and D). In fact, Hcm1 half-life was modestly decreased 
after CaCl2 treatment. Of importance, deletion of the CN docking 
site or expression of wild-type Hcm1 in a CN-deficient strain also did 
not lengthen Hcm1 half-life (Figure 3, C and D), and deletion of the 
CN docking site did not affect cell cycle–regulated expression of 
Hcm1 (Supplemental Figure S2A). Together these data support the 
finding that the N-terminal phosphosites in Hcm1 are not targeted 
by CN. They also suggest that there may be an active mechanism to 
further destabilize Hcm1 when cells are exposed to stress. This de-
stabilization appears to be independent of CN and Cdk1, since the 
half-life of all mutants were shortened. One possibility is that the 
previously identified Cdk1-independent mode of Hcm1 degrada-
tion that occurs in G1 phase (Landry et al., 2014) may be enhanced 
to promote a further reduction in Hcm1 activity.
We next examined whether CN might affect Hcm1 activity, by 
analyzing previous genome-wide expression data (Yoshimoto 
et al., 2002) to determine whether Hcm1 target genes change in 
expression in response to CN activation. Of interest, we found 
FIGURE 3: Calcineurin removes activating phosphorylations from Hcm1. (A) Strains expressing 
indicated Hcm1 proteins were treated with CaCl2 for 10 min and phosphorylation assayed by 
Phos-tag Western blot. Note that the top band in the 12C sample is also present in the 15A 
sample, suggesting that it is the result of Cdk1-independent phosphorylation. (B) Cdk1-
phosphorylated Hcm1 proteins were incubated with or without CN for 45 min. Average 
percentage phosphorylation remaining is shown ± 1 SD (n = 3). Hcm1ΔPSIEIQ is significantly 
different from wild-type Hcm1 (*p < 0.05, Student's t test). Also see Supplemental Figure S1B. 
(C) Cycloheximide-chase assays comparing the stability of Hcm1 proteins with or without CaCl2 
treatment. (D) Average data from five experiments were used to calculate half-life values 
(indicated in parentheses) of each protein with or without CaCl2.
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which, unlike hcm1-16E and hcm1ΔPSIEIQ, 
is highly resistant to benomyl (Supplemental 
Figure S2C). Of note, hcm1-3N cells showed 
similar resistance to CN-activating stresses as 
cells expressing Hcm1ΔPSIEIQ, Hcm1-16E, 
or mutants that combined either the ΔPSIEIQ 
mutation or the 16E mutation with the 3N 
mutation (Figure 5, C and D). Thus Hcm1 
activity limits proliferation during some stress 
conditions, and increasing either its level or 
activity through modulation of its phosphory-
lation state results in increased proliferation.
 The wide array of CN targets that have 
been identified thus far suggests that CN or-
chestrates a global, integrated response to 
stress by affecting numerous regulatory 
pathways in order to promote cell survival in 
response to environmental stress (Heath 
et al., 2004; Bultynck et al., 2006; O'Donnell 
et al., 2013; Alvaro et al., 2014; Goldman 
et al., 2014; Guiney et al., 2015). In this study, 
we identify Hcm1 as an additional target and 
elucidate how CN connects this global stress 
response with changes in the cell cycle–regu-
latory network. In addition, we demonstrate 
that Hcm1 is a key node in the cell cycle net-
work that relays signals from the extracellular 
environment to control proliferation. This is 
supported by our finding that increases or 
decreases in Hcm1 phosphorylation can pos-
itively or negatively affect fitness (Figure 1) 
and that in response to stress, CN targets a 
subset of Hcm1 phosphosites. Of impor-
tance, there are two groups of Cdk1 phos-
phorylation sites that have opposing effects 
on Hcm1 activity, and CN specifically targets 
the group of sites that promote Hcm1 func-
tion (Figure 3). By dephosphorylating activat-
ing sites while sites that promote degrada-
tion remain intact, CN rapidly extinguishes 
Hcm1 activity. Similarly, an additional phos-
phatase may regulate Hcm1 stability by de-
phosphorylating the N-terminal Cdk1 sites, 
thereby increasing Hcm1 levels. Thus Hcm1 
activity is differentially modulated by multi-
ple regulators, which likely respond to dis-
tinct signals. Because its activity is limiting for 
maximal proliferation, we propose that 
Hcm1 serves as a biological rheostat that in-
tegrates multiple signals from kinases and phosphatases to produce 
a broad continuum of proliferation rates. Further, this mode of cell 
cycle regulation might be conserved, as several transcription factors 
that control late–cell cycle gene expression in human cells are simi-
larly regulated by Cdk phosphorylation (Sadasivam and DeCaprio, 
2013). Understanding the role of phosphatases in transmitting signals 
to the cell cycle–regulatory network is key to elucidating how cell 
cycle progression is finely tuned to match the cellular environment.
MATERIALS AND METHODS
Yeast strains and growth conditions
A complete list of strains used in each experiment is given in 
Supplemental Table S1. All strains are in the S288c background 
stress (Levin, 2011), so we next examined the importance of Hcm1 
dephosphorylation for the cellular response to these stresses. Of in-
terest, cells expressing Hcm1 mutants with varying amounts of activ-
ity responded differently to different classes of CN-activating stresses. 
The presence or absence of Hcm1 activity had no effect on survival 
when cells were exposed to alkaline stress (Supplemental Figure S3). 
However, Hcm1 activity was important for the response to cell wall 
stress and LiCl, both of which promote Hcm1 dephosphorylation 
(Figure 5B). Deletion of HCM1 sensitized cells to both types of stress 
(Figure 5, C and D, and Supplemental Figure S3), and when Hcm1 
dephosphorylation was impaired (by deletion of the docking site or 
expression of the phosphomimetic mutant), proliferation was en-
hanced (Figure 5, C and D). We also examined the hcm1-3N strain, 
FIGURE 4: Calcineurin inactivates Hcm1. (A) Changes in expression of predicted Hcm1 target 
genes (Pramila et al., 2006) in response to CaCl2 treatment with or without the CN inhibitor 
FK506. Data are from Yoshimoto et al., (2002). Cluster 1 includes 49 of 91 genes that are 
down-regulated (less than [−0.5 log 2]-fold change) at the 30-min time point. Cluster 2 includes 
the remaining 42 genes. (B) Average expression of genes in each cluster over time with or 
without FK506. For cluster 1, average values with or without FK506 are significantly different at 
each time point (p < 0.0001, paired t test); for cluster 2, average values with or without FK506 
are not significantly different at any time point. (C) Reverse transcription quantitative PCR of 
Hcm1 target genes 30 min after the addition of CaCl2. Fold change values were calculated by 
comparing expression after 30 min to expression in the same strain before treatment. Average 
log 2–fold change values ±1 SD (n = 6). Down-regulation was significantly impaired in each 
mutant strain compared with wild type. ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05.
Volume 26 October 15, 2015 Regulation of Hcm1 by calcineurin | 3575 
Cells were grown in either rich medium (YM-1 complete medium 
with 2% dextrose; Benanti et al., 2007) or synthetic medium 
(C medium with 1% ammonium chloride, 2% dextrose) at 30°C. For 
Ca2+ treatments, cells were grown overnight in rich medium and 
then transferred into synthetic medium and allowed to grow for at 
least one cell cycle. Cells were then treated with 200 mM CaCl2 for 
the indicated times. Where indicated, cells were pretreated with 
1 μg/ml FK506 (LC Laboratories, Woburn, MA) in ET buffer (90% 
ethanol and 10% Tween-20) or ET buffer alone for 1 h before CaCl2 
treatment. Where indicated, exponentially growing cells in rich 
medium were treated with 500 mM LiCl for 5 min or 250 μg/ml 
Congo red for 10 min. For cell cycle analysis, cells were arrested in 
G1 phase in rich medium containing 10 μg/ml α-factor for 2 h and 
then released into medium without α-factor. Flow cytometry to con-
firm cell cycle position was carried out as previously described 
(Landry et al., 2014).
Yeast two-hybrid assay
Strain PJ69-4A was transformed with GAL4-DBD and GAL4-ACT fu-
sion plasmids: BJP2014 (CNA1-GAL4 activation domain fusion, 
LEU2), pACT2 (GAL4 DNA-binding domain [DBD], TRP1), pACT2-
HCM1 (HCM1-GAL4 DBD fusion, TRP1), and pACT2-hcm1ΔPSIEIQ 
(hcm1ΔPSIEIQ-GAL4 DBD fusion, TRP1). Cotransformants were 
scored for growth on synthetic media with or without histidine by 
dilution plating: from 0.5 to 1 OD600 unit of cells from each culture 
were serially diluted fivefold to sixfold in distilled water and spotted 
on plates. Plates were incubated at 30°C for 2–3 d.
In vivo CN interaction assay
Strain YEG2 (Guiney et al., 2015) was transformed with plasmids 
pGAL-HCM1 (Landry et al., 2014), pGAL-hcm1-3N (Landry et al., 
2014), and pGAL-hcm1ΔPSIEIQ (same as pGAL-HCM1 with 
hcm1ΔPSIEIQ) or vector (GAL-YEP352). Transformants were grown 
to mid log phase in synthetic media lacking histidine and containing 
2% raffinose. Expression of the GAL1 promoter was induced with 
2% galactose for 4 h, and 200 mM CaCl2 was added to the cultures 
for 15 min to activate CN. Cells were then pelleted, washed, and 
frozen at −80°C. Cell lysates were prepared as described (Goldman 
et al., 2014), and 10 mg of cell lysates was incubated with 30 μl of 
immunoglobulin G–Sepharose (GE Healthcare, Pittsburgh, PA) for 
3 h at 4°C. ZZ-tagged complexes were then precipitated and 
washed twice with buffer. Bound proteins were eluted by boiling in 
2× SDS-dye and examined by SDS–PAGE and Western analysis with 
a LI-COR detection system. Monoclonal anti-HA antibody (12CA5) 
was used to detect HA-tagged proteins, and a polyclonal anti–S-tag 
antibody (kind gift from R. Kopito, Stanford University) was used to 
detect Cna2-S-ZZ.
Competition assays
Competition assays were performed as previously described (Torres 
et al., 2010; Landry et al., 2014). An equal amount of cells with or 
without PGK1-GFP was mixed together and diluted every 12 h to 
maintain logarithmic-phase growth. Cells were fixed at each time 
point in 100% ethanol for analysis by flow cytometry using a FACS-
can (Becton Dickson, Franklin Lakes, NJ). Data were analyzed for GFP 
fluorescence using FlowJo (FLOWJO, LLC, Ashland, OR) software.
Western blotting
Cell pellets (1 OD600 nm) were lysed in trichloroacetic acid (TCA), and 
Western blotting was carried out as previously described (Landry 
et al., 2014), with antibodies against HA (12CA5), Cdc28 (sc-6709; 
Santa Cruz Biotechnology, Santa Cruz, CA). For Phos-tag gels, the 
except for PJ69-4A (which is W303). For all HCM1 mutations, PCR 
products containing the desired mutations were integrated with a 
triple hemagglutinin epitope tag (3HA) and the HIS3MX cassette at 
the genomic locus using standard techniques. Each HCM1 mutation 
was confirmed by sequencing. The HCM1 cnb1Δ strain was gener-
ated by replacing the CNB1 gene with a KanMX cassette in the 
Hcm1-3HA–tagged strain.
FIGURE 5: Hcm1 inactivation limits proliferation in response to 
environmental stress. (A) Indicated strains were cocultured and the 
percentage of each population at each time point quantified by flow 
cytometry. Average values ± 1 SD (n = 13). (B) Strains expressing the 
indicated Hcm1 proteins were treated with Congo red (cell wall stress) 
for 10 min or LiCl for 5 min and phosphorylation assayed by Phos-tag 
Western blot. (C) Fivefold dilutions of the indicated strains were 
spotted onto synthetic complete medium (SC) with or without Congo 
red. (D) Fivefold dilutions of the indicated strains were spotted onto 
rich medium (YPD) with or without LiCl.
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2× SYBR Fast Master Mix Universal (Kapa Biosystems, Wilmington, 
MA) and the primers to the indicated genes (Landry et al., 2014). 
Reactions were conducted on a Mastercycler ep realplex (Eppen-
dorf, Hamburg, Germany). mRNA levels were normalized to ACT1. 
Fold change was calculated by comparing normalized expression of 
each target gene after 30 min of CaCl2 treatment to the expression 
of the target in the same strain before CaCl2 addition.
Serial dilution assays
Exponentially growing cells were serially diluted fivefold and spot-
ted onto the indicated plates. Synthetic medium plates (SC with 1% 
ammonium chloride, 2% dextrose) contained 500 μg/ml Congo red 
and 188 μg/ml Fluorescent Brightener 28 (Calcofluor White; Sigma-
Aldrich, St. Louis, MO), where indicated. Lithium chloride, 450 mM, 
or 15–20 μg/ml benomyl was added to rich media plates (yeast 
extract/peptone/2% dextrose [YPD]) where indicated. Plates were 
incubated at 30°C for 1–3 d.
resolving gel contained 6 or 7% acrylamide/bis solution 29:1 
(Bio-Rad, Hercules, CA), 386 mM Tris-Cl, pH 8.8, 0.1% SDS, 0.2% 
ammonium persulfate (APS), 25 μM Phos-tag acrylamide, 50 μM 
manganese chloride, and 0.17% tetramethylethylenediamine 
(TEMED). The stacking gel contained 5% acrylamide/bis solution 
37.5:1 (Bio-Rad), 126 mM Tris-Cl, pH 6.8, 0.1% SDS, 0.1% APS, and 
0.04% TEMED. TCA-extracted samples were run on Phos-tag gels 
at 140 V for ∼2 h, and then gels were washed twice in 100 ml of 
transfer buffer containing 10 mM EDTA for 15 min and once in 50 ml 
of transfer buffer for 10 min before being transferred to a nitrocel-
lulose membrane for 2–3 h at 0.45 A.
In vitro dephosphorylation assays
Hcm1 and indicated mutants were cloned into the pET32mLic vec-
tor (hexahistidine-tagging vector), expressed in bacteria, and puri-
fied on Ni nitriloacetic acid agarose beads (Qiagen, Hilden, 
Germany) according to manufacturer's specifications. Proteins were 
eluted and stored in buffer containing 50 mM Tris-HCl, pH 7.5, 
150 mM NaCl, 1 mM β-mercaptoethanol, and 10% glycerol. From 
20 to 30 μg of purified protein was phosphorylated by Clb2/Cdk1/
Cks1 complex) a kind gift from M. Kõivomägi and J. Skotheim 
(Stanford University) in kinase buffer (50 mM 4-(2-hydroxyethyl)-1-pi-
perazineethanesulfonic acid, pH 7.4, 150 mM NaCl, 5 mM MgCl2, 
500 mM ATP) containing [γ-32P]ATP as in Kõivomägi et al. (2011) for 
16 h at room temperature. Phosphorylated proteins were purified 
from unincorporated ATP using a Centri-sep (Applied Biosystems, 
Waltham, MA) column and eluted into dephosphorylation buffer 
(50 mM Tris, pH 7.5, 150 mM NaCl, 10 mM EDTA). Phosphorylated 
proteins were then split into two reactions. Purified activated yeast 
calcineurin (Goldman et al., 2014) was added to one reaction, and 
an equal volume of buffer was added to the other. Dephosphoryla-
tion was carried out at room temperature and samples withdrawn at 
0, 45, and 90 min. Samples were boiled in SDS buffer and stored at 
−20°C. The extent of CN-mediated dephosphorylation was mea-
sured as in Goldman et al. (2014). Briefly, samples were subjected to 
SDS–PAGE, and the gels were stained by Gel Code blue reagent 
(Thermo Scientific, Waltham, MA) and then dried on a gel dryer. 
Total protein amounts were determined using ImageJ (National In-
stitutes of Health, Bethesda, MD) software analysis of the stained 
protein bands, and [γ-32P]ATP incorporation was measured by analy-
sis of an exposed phosphorimager screen with the Typhoon Scanner 
and ImageJ software. Storage phosphor counts were normalized to 
protein levels to determine the extent of ATP incorporation in the 
presence or absence of CN.
Cycloheximide-chase assays
Cells were grown to mid log phase, and 50 μg/ml cycloheximide 
was added to block protein synthesis. Cells at 1 OD600 nm were col-
lected at the indicated time points and samples analyzed by West-
ern blotting. Western blots from cycloheximide-chase assays were 
quantified using a ChemiDoc Touch imaging system (Bio-Rad). 
Hcm1-3HA signals were normalized to Cdk1 as a loading control, 
and half-life values from an average of five experiments were calcu-
lated using GraphPad Prism software.
Reverse transcription quantitative PCR
Total RNA was isolated from 5 OD600 nm of pellets from asynchro-
nous cells as described (Schmitt et al., 1990), digested with DNaseI 
(New England BioLabs, Ipswich, MA), and ethanol precipitated. 
Reverse transcription was carried out using 2 μg of RNA and random 
primers (Invitrogen, Waltham, MA), then treated with RNaseH (New 
England BioLabs). Reverse transcription products were mixed with 
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